AAO-HNS GUIDELINES Bundle (free trial)

Immunotherapy for Inhalant Allergy

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1516464

Contents of this Issue

Navigation

Page 9 of 15

10 Treatment Table 5. Differentiating Between Vasovagal and Anaphylaxis Vasovagal Anaphylaxis Onset Immediate, usually within minutes Typically within 30 minutes Neurologic Fainting sensation, light headedness, dizziness Sense of severe anxiety and distress Respiratory Normal breathing, no cough, no hoarseness Dyspnea, wheezing, stridor, hypoxemia, inability to maintain airway patency, persistent cough, throat clearing Cardiovascular Bradycardia, hypotension Tachycardia, hypotensive Gastrointestinal Nausea, vomiting Abdominal cramps, diarrhea, nausea, vomiting Skin Generalized pallor, cool, clammy skin, absence of urticaria and angioedema Pruritis, generalized erythema, urticaria, angioedema

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Immunotherapy for Inhalant Allergy